Drug Shortage Report for MAR-TADALAFIL
Report ID | 99682 |
Drug Identification Number | 02452243 |
Brand name | MAR-TADALAFIL |
Common or Proper name | Tadalafil |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 Tablets |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-11-29 |
Actual start date | 2019-11-28 |
Estimated end date | 2020-01-03 |
Actual end date | 2020-01-03 |
Shortage status | Resolved |
Updated date | 2020-01-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2020-01-04 | English | Compare |
v13 | 2020-01-02 | French | Compare |
v12 | 2020-01-02 | English | Compare |
v11 | 2019-12-19 | French | Compare |
v10 | 2019-12-19 | English | Compare |
v9 | 2019-12-19 | French | Compare |
v8 | 2019-12-19 | English | Compare |
v7 | 2019-12-16 | French | Compare |
v6 | 2019-12-16 | English | Compare |
v5 | 2019-11-29 | English | Compare |
v4 | 2019-11-27 | French | Compare |
v3 | 2019-11-27 | English | Compare |
v2 | 2019-11-26 | French | Compare |
v1 | 2019-11-26 | English | Compare |
Showing 1 to 14 of 14